Seminars in Oncology
Volume 30, Issue 2 , Pages 110-115, April 2003

Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia☆☆☆

Leeds General Infirmary, Leeds, UK; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Van Elslander Cancer Center, Grosse Point Woods, MI; Mayo Clinic, Rochester, MN; National Cancer Institute, Bethesda, MD; Niguarda Ca'Granda Hospital, Milan, Italy; University of Salamanca, Salamanca, Spain; and the University of Athens, Athens, Greece

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Address reprint requests to Waldenstrom's Macroglobulinemia Program, Dana Farber Cancer Institute, Harvard Medical School, LG100, 44 Binney St, Boston, MA 02115. Email: wmp@dfci.harvard.edu.

☆☆ 0093-7754/03/3002-0002$30.00/0

PII: S0093-7754(03)70059-1

doi:10.1053/sonc.2003.50082

Seminars in Oncology
Volume 30, Issue 2 , Pages 110-115, April 2003

Article Tools